Study | Total participants | Number of AKI | AUC | Sensitivity | Specificity | True positive | True negative | False positive | False negative |
---|---|---|---|---|---|---|---|---|---|
Aykut, 2022 | 455 | 141 | NR | 0.24 | 0.84 | 34 | 264 | 50 | 107 |
Dolapoglu, 2019 | 336 | 88 | 0.792 (0.728–0.856) | 0.66 | 0.92 | 58 | 228 | 20 | 30 |
Efe, 2021 | 360 | 91 | NR | 0.52 | 0.80 | 47 | 216 | 53 | 44 |
Gucu, 2021 | 255 | 82 | 0.711 (0.649–0.774) | 0.67 | 0.77 | 55 | 133 | 40 | 27 |
Han, 2021 | 3731 | 271 | 0.707 | 0.56 | 0.76 | 152 | 2638 | 822 | 119 |
Hatem, 2023 | 336 | 68 | 0.732 | 0.71 | 0.69 | 48 | 186 | 82 | 20 |
Hu (test), 2021 | 6444 | 4457 | 0.755 (0.734–0.775) | 0.64 | 0.82 | 2830 | 1625 | 362 | 1627 |
Hu (validation), 2021 | 412 | 130 | 0.738 (0.685–0.791) | 0.75 | 0.65 | 97 | 182 | 100 | 33 |
Jing, 2021 | 584 | 98 | 0.553 (0.489–0.617) | 0.65 | 0.47 | 64 | 230 | 256 | 34 |
Kurtul, 2021 | 836 | 79 | 0.836 (0.788–0.805) | 0.82 | 0.70 | 65 | 530 | 227 | 14 |
Lee, 2019 | 374 | 31 | 0.57 | 0.39 | 0.74 | 12 | 255 | 88 | 19 |
Li, 2022 | 4386 | 3599 | 0.629 (0.603–0.655) | 0.80 | 0.40 | 630 | 1440 | 2159 | 157 |
Min, 2020 | 423 | 54 | 0.749 (0.705–0.790) | 0.70 | 0.74 | 38 | 273 | 96 | 16 |
Shimoyama, 2021 | 83 | 6 | 0.72 | 0.67 | 0.94 | 4 | 72 | 5 | 2 |
Shimoyama, 2022 | 61 | 38 | 0.6 | 0.58 | 0.67 | 22 | 15 | 8 | 16 |
Xie, 2022 | 1238 | 507 | 0.760 (0.731–0.789) | 0.87 | 0.64 | 441 | 466 | 265 | 66 |
Yuksel, 2023 | 925 | 232 | 0.87 (0.84–0.89) | 0.80 | 0.81 | 188 | 554 | 139 | 44 |